Sight Sciences Q4 EPS Loss of $0.08 Beats Estimate, Revenue $20.4M
Sight Sciences posted a Q4 EPS loss of $0.08 versus a $0.15 loss estimate and generated $20.39 million in revenue, up from $19.07 million year-over-year. Shares have fallen 33.7% since January as the company delivers its fourth consecutive EPS beat.
1. Q4 Financial Results
Sight Sciences reported a Q4 adjusted loss of $0.08 per share versus a consensus loss estimate of $0.15, marking a 44.8% positive surprise. Revenue for the quarter reached $20.39 million, a 6.9% increase from $19.07 million year-over-year and 0.34% above estimates.
2. Consecutive Beats and Performance Trend
This marks the fourth straight quarter in which the company has topped EPS and revenue consensus estimates. The Q4 loss narrowed from $0.23 per share a year ago, reflecting ongoing operational improvements in the Medical Instruments segment.
3. Stock Movement and Outlook
Sight Sciences shares have declined 33.7% since the start of the year, underperforming the broader market. Consensus forecasts for the upcoming quarter call for an EPS loss of $0.18 on $19.29 million in revenue, with investors focusing on management commentary for directional cues.